American Express Company

New York Stock Exchange
Slightly Bullish +15

Boston Trust Walden Corp Trims Stock Holdings in American Express ...

πŸ“‰ Boston Trust Walden Corp decreased its AXP holdings by 5.6% in Q1, selling 13,540 shares while retaining a $68.5 million position.

πŸ“ˆ Goldman Sachs raised its price target to $400 and issued a 'buy' rating, contrasting with JPMorgan's downgrade to a $325 target.

πŸ’° American Express reported Q1 EPS of $4.28, beating estimates, though revenue of $14.21 billion missed the consensus forecast of $18.60 billion.

πŸ“… The company declared a quarterly dividend of $0.95 per share with an ex-dividend date of July 2nd and payment on August 10th.

🎯 Analysts have set an average price target of $366.95, while the stock trades near its 50-day moving average of $322.13.

πŸ“Š The firm maintains a strong balance sheet with a quick ratio of 1.56 and a return on equity of 33.95%.

Bullish Signals
  • American Express beat quarterly EPS estimates by $0.27, reporting $4.28 per share compared to the consensus of $4.01.
  • Goldman Sachs Group increased its price objective to $400 and upgraded the rating to 'buy', signaling confidence in future performance.
  • The company reported a robust net margin of 15.13% and a high return on equity of 33.95%, indicating efficient capital use.
  • Revenue grew by 11.4% year-over-year, demonstrating underlying business growth despite the absolute miss against analyst expectations.
  • The firm has established a consistent dividend policy with a payout ratio of 23.71% and an annualized yield of 3.80%.
Risk Factors
  • American Express revenue of $14.21 billion significantly missed the analyst consensus estimate of $18.60 billion, raising concerns about top-line execution.
  • JPMorgan Chase & Co. decreased its price target to $325 and assigned a 'neutral' rating, reflecting caution regarding current valuations.
  • Barclays lowered its price target from $323 to $322 and maintained an 'equal weight' rating, indicating limited upside potential in the near term.
  • The stock trades below its 200-day moving average of $333.14, suggesting some short-term bearish pressure or lack of immediate momentum.
Full Analysis
Boston Trust Walden Corp reduced its holdings in American Express (AXP) by 5.6% during the first quarter, selling 13,540 shares to leave a position of 226,586 shares valued at $68.5 million. While this major institutional investor trimmed its stake, several smaller firms like Evolution Wealth Management Inc. and Joseph Group Capital Management initiated or increased positions in the fourth quarter, though their holdings remain negligible compared to the company's total market capitalization of approximately $239.95 billion. Analyst sentiment regarding American Express remains mixed with a consensus 'Moderate Buy' rating and an average price target of $366.95. Major banks have issued divergent guidance: Goldman Sachs raised its target to $400 with a 'buy' rating, while JPMorgan Chase lowered its target to $325 with a 'neutral' rating. Barclays also downgraded its target slightly to $322, maintaining an 'equal weight' stance, reflecting ongoing debate over the stock's valuation and growth prospects. Financially, American Express reported strong earnings for the quarter ended April 23rd, posting $4.28 in EPS which beat analyst estimates of $4.01. However, revenue came in at $14.21 billion, significantly missing the consensus estimate of $18.60 billion, resulting in a net margin of 15.13%. The company has provided FY 2026 guidance for EPS between $17.30 and $17.90, with analysts expecting an average of $17.65. Additionally, the firm declared a quarterly dividend of $0.95 per share payable on August 10th to shareholders of record as of July 2nd.